Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost

Contemporary Clinical Trials - Netherlands
doi 10.1016/j.cct.2015.08.006

Related search